SureTrader
Interactive Brokers Advertisement
Home > Boards > US Listed > Biotechs >

Viking Therapeutics, Inc. (VKTX)

VKTX RSS Feed
Add VKTX Price Alert      Hide Sticky   Hide Intro
Moderator: greens12, BrazenBull
Search This Board: 
Last Post: 10/21/2017 11:12:27 PM - Followers: 31 - Board type: Free - Posts Today: 0

 
Novel therapeutics for metabolic<Br/>and endocrine disorders
  1. 2
    2
    2
     
 

VK0612

Viking Therapeutics is focused on the development of novel therapeutics for patients suffering from metabolic and endocrine disorders.

Viking Therapeutics is a clinical-stage biotherapeutics company focused on the development of novel, first-in-class or best-in-class therapies for metabolic and endocrine disorders. Viking’s research and development activities leverage the Company’s expertise in metabolism to develop innovative therapeutics that improve patients’ lives. The Company’s lead clinical program is VK5211, an orally available, non-steroidal selective androgen receptor modulator, or SARM, for the treatment of patients recovering from non-elective hip fracture surgery. The Company’s second program is focused on the development of first-in-class, selective, small molecule agonists of the thyroid receptor beta, or TRß, for adrenoleukodystrophy, or ALD, and lipid disorders such as hypercholesterolemia and non-alcoholic steatohepatitis, or NASH. Viking is also developing additional programs targeted at diabetes, metabolic diseases and anemia.
 

Overview

Pills

We have a portfolio of five drug candidates in clinical trials or preclinical studies

Our lead clinical program, VK5211, is a novel, orally available, non-steroidal selective androgen receptor modulator, or SARM, in development for the treatment of patients recovering from non-elective hip fracture surgery. VK5211 is designed to produce the therapeutic benefits of testosterone in muscle and bone with improved safety, tolerability and patient acceptance. We have initiated a Phase 2 clinical trial with VK5211 in patients recovering from non-elective hip fracture surgery. For more information on this study please visit NCT02578095.

Our second pipeline program is focused on the development of novel small molecule agonists of the thyroid beta (TRb) receptor, VK2809 and VK0214. These novel TRb agonists are being developed for hypercholesterolemia and fatty liver disease and X-linked adrenoleukodystrophy, or X-ALD. We have initiated Phase 2 clinical development of VK 2809 in hypercholesterolemia and fatty liver disease. VK0214 is in preclinical development for X-ALD.

We are also developing VK0612, a first-in-class, orally available drug 

SureTrader
Interactive Brokers Advertisement
VKTX
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
VKTX News: Securities Registration Statement (s-1) 10/17/2017 04:49:11 PM
VKTX News: Viking Therapeutics Announces Top-Line Results from Proof-of-Concept Study of VK0214 in In Vivo Model of X-Linked Adrenoleuko... 10/04/2017 07:05:00 AM
VKTX News: Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) 09/29/2017 04:46:11 PM
VKTX News: Current Report Filing (8-k) 09/29/2017 07:06:35 AM
VKTX News: Viking Therapeutics Announces Purchase Agreements for up to $16.25 Million with Lincoln Park Capital 09/29/2017 07:05:00 AM
PostSubject
#695   Are you also as excited about vk5211? zoomlik 10/03/17 10:04:46 PM
#694   Yes, setting the stage for VK2809 which IMO greens12 10/03/17 09:53:43 PM
#693   So, I think mdgl p2 readout in Q4 zoomlik 10/03/17 09:06:45 PM
#692   That’s the question and that’s why we are bullish. Lynx7 10/03/17 09:05:01 PM
#691   Why MDGL is valued 10 times higher? $600M zoomlik 10/03/17 07:16:06 PM
#690   Maxim is not credible .. Zack is good zoomlik 10/03/17 09:55:53 AM
#689   Zacks has a 7.00 target, Maxim Group 5.00 greens12 10/02/17 07:30:54 PM
#688   What are price targets or market cap targets zoomlik 10/02/17 05:38:21 PM
#687   Yes! This seems to be an afternoon runner. Titan V 10/02/17 11:48:54 AM
#686   A breakout above 2.00 could happen at any greens12 10/02/17 11:38:56 AM
#685   You mite need to do some digging. Not BrazenBull 10/02/17 10:07:16 AM
#684   Exactly. Ligand stands to gain a lot of Titan V 10/02/17 09:01:19 AM
#683   This arrangement is consistent with the Ligand business bigjake 10/02/17 08:45:45 AM
#682   My question has always been if this drug gilotron 10/02/17 06:27:29 AM
#681   Given the recent movement in price, I am BrazenBull 10/01/17 07:42:29 PM
#680   What's the chance of the test passing? gilotron 10/01/17 07:10:48 PM
#679   It is indeed. I'm not sure if it Titan V 09/30/17 08:04:36 PM
#678   $VKTX has 13 Mil. in the bank and greens12 09/30/17 08:03:29 PM
#677   Thanks for the link. Very exciting. ZeWaffleBaron 09/30/17 07:49:30 PM
#676   Well then, It looks as if we will greens12 09/30/17 07:19:52 PM
#675   That's what I thought as well. By the Titan V 09/30/17 06:01:45 PM
#674   VK5211 on deck 10/9 , I'm not sure greens12 09/30/17 04:51:52 PM
#673   Besides musculoskeletal data, do we anticipate any other Titan V 09/30/17 02:53:09 PM
#672   wow 2.00 AH ...it traded all over greens12 09/29/17 08:39:04 PM
#671   What a Epic week it was, congrats to greens12 09/29/17 08:34:19 PM
#670   $2 and close to 10k volume after hours. Titan V 09/29/17 06:12:50 PM
#669   No joke! :-D Looking good Patience And Perspective $VKTX Cbdpotential 09/29/17 02:42:10 PM
#668   good to see you here,Stick around, the Party greens12 09/29/17 11:12:57 AM
#667   Haven't gone anywhere ;-) Much love brother Cbdpotential 09/29/17 12:06:28 AM
#666   miss ya brother!! BrazenBull 09/29/17 12:04:41 AM
#665   Nice! Cbdpotential 09/28/17 11:56:11 PM
#664   The way its moving up tells me greens12 09/28/17 08:35:59 PM
#663   Love it. Let’s make some money boys. Lynx7 09/28/17 05:37:58 PM
#662   What a day! Will be fun going into Titan V 09/28/17 04:11:40 PM
#661   VKTX on fire.... chart looks A+ perfect for greens12 09/28/17 03:01:40 PM
#660   Great call buddy! What a trading week... ZeWaffleBaron 09/28/17 02:51:24 PM
#659   called it...Just hit 1.74, 52 week high, bullish greens12 09/28/17 02:37:17 PM
#658   I feel that the ambiguity of this expert ZeWaffleBaron 09/28/17 08:10:12 AM
#657   Hey Bull, I think you are likely correct. ZeWaffleBaron 09/28/17 08:03:52 AM
#656   I still think it will test 52 week greens12 09/28/17 01:25:22 AM
#655   I agree. Another bio I follow had discussed Titan V 09/27/17 11:20:21 PM
#654   Agreed Titan, they announced that enrolment was BrazenBull 09/27/17 11:07:16 PM
#653   Thanks BrazenBull! Glad to be here. I think Titan V 09/27/17 10:30:22 PM
#652   Hello Titan! Welcome to the board! Happy to BrazenBull 09/27/17 10:25:44 PM
#651   We have had a very nice run the BrazenBull 09/27/17 10:20:18 PM
#650   Man the more I read about vk2809 the Lynx7 09/27/17 07:30:40 PM
#649   Volume so far today is strong, looks greens12 09/27/17 11:49:50 AM
#648   Strongly agree. Any things possible, but this ZeWaffleBaron 09/27/17 08:44:56 AM
#647   I agree. They have full control over when Titan V 09/26/17 06:49:10 PM
#646   Do U think they'd have this presentation prior bigjake 09/26/17 05:02:54 PM
PostSubject